Annolyse
BriefingsCompaniesScreenerInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Screener
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources
←Back to briefings
Templeton Emerging Markets Investment Trust Plc (TEM) / FY22

Portfolio fell 17.3% and trailed MSCI EM by 10.5pp

TEMIT cut the ordinary distribution to 3.80p as net assets fell 18.9% to 2,100.4m, with gross borrowings rising 50% to 150.0m.

Investment Companies / Listed investment trust

NTA/NAV per share

Net tangible asset or net asset value per share, shown in per-share cents for chart readability.

↗
Loading chart...
FY22 was 178.2c, versus 200.3c in HY22.

Investment income

Recurring investment-income or revenue-return proxy, excluding fair-value movement where disclosed.

↗
Loading chart...
FY22 was $54.3m, versus $32.3m in HY22.

Investment total return

Total income or return including fair-value or capital movement where disclosed.

↗
Loading chart...
FY22 was -$442.4m, versus -$191.9m in HY22.

Net assets attributable

Net asset base attributable to shareholders or unitholders.

↗
Loading chart...
FY22 was $2.1b, versus $2.4b in HY22.

Market context

Valuation

A close-dated read on what the market price implies next to the latest verified filing inputs. Unavailable metrics stay visible when the absence is useful context.

Prices as at close, 8 June 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$6.9b

i

End-of-day close multiplied by current shares on issue.

Income and fund shape

Yield and fund-style valuation where the company shape supports it.

Dividend yield

1.6%

i

Trailing dividends compared with the latest close.

Premium / discount

334.0%

i

For investment companies, price compared with reported NTA.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not available for this company right now.

EPS

Not available

i

Not available for this company right now.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not useful for this reporting shape.

P/FCF

Not available

i

Not available for this company right now.

Release date
15 June 2022
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Valuation
  3. Analysis
  4. Chat
  5. Data
  6. Sources

Key metrics

Numbers worth scanning first

FY22 vs FY21

Net profit after tax

−$442.4m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net cash inflow from operating activities

$27.5m

-46.5% ↓ vs $51.5m

Final dividend per share

3.8c

-72.9% ↓ vs 14.0c

Investment income

$54.3m

+89.5% ↑ vs $28.6m

Operating profit

−$429.9m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Profit before tax

−$432.7m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Cash and cash equivalents

$125.9m

+47.7% ↑ vs $85.2m

Total assets

$2.3b

-12.5% ↓ vs $2.6b

What changed

The portfolio delivered a total return of -17.3% for the year against an MSCI Emerging Markets benchmark return of -6.8%, an active underperformance of 10.5 percentage points

Net assets attributable to shareholders fell 18.9% to 2,100.4m from 2,591.3m, and the headline total return (which for an investment company captures both income and fair-value movements) swung to a loss of 442.4m from a 934.4m gain the prior year — a -147.3% movement.

Investment income on a like-for-like basis fell 9.4% to 54.3m from 59.9m. The ordinary distribution for the year was set at 3.80p per share (1.00p interim plus 2.80p proposed final), down from 19.00p ordinary plus a 10.00p special the prior year. Gross borrowings rose 50% to 150.0m, comprising a 100.0m fixed-term loan and a new 50.0m revolving credit drawing.

What matters

Active positioning amplified the drawdown, not cushioned it

The benchmark itself fell 6.8%, but the trust's portfolio fell 17.3%, leaving the manager 10.5pp behind a peer index during a year of broad emerging-market weakness. The expense ratio held at 0.97%, so this is a stock-selection and country-allocation outcome rather than a cost issue, which makes it the more important read on manager performance.

Distribution coverage improved on a much lower base. Distribution coverage rose to 121% from 86.7%, so the proposed 3.80p ordinary dividend is more than covered by current-period revenue earnings. That sustains the income story in coverage terms, but the absolute step-down from a combined 29.00p prior-year payment (ordinary plus special) is a material reduction in cash income for holders.

Gearing rose into a falling market. Gross borrowings increased 50.0m to 150.0m while net assets fell 18.9%, which means borrowings as a proportion of net assets has roughly doubled. This raises NAV sensitivity to further portfolio drawdowns and is the balance-sheet item most likely to compound, rather than offset, future emerging-market weakness.

Expectations

No forward targets, guidance, or repositioning commentary are supplied

The interim commentary noted that the majority of TEMIT's revenue earnings are typically received in the first half, and the implied second-half investment income share of around 40% is consistent with that seasonal pattern, so the income shortfall is not a late-year shock.

What the release does not support is a view on whether the active underperformance reflects deliberate positioning expected to recover, or stock-selection drag that will persist. There is no manager commentary in the supplied excerpts on outlook for emerging markets, country tilts, or planned portfolio changes.

Quality of result

For an investment company the relevant quality test is income durability, expense discipline, and the basis of total return

Revenue earnings of 54.3m cover the proposed ordinary distribution at 121%, so on a current-year basis the dividend is funded from income rather than capital. The expense ratio was steady at 0.97%, indicating cost discipline did not deteriorate.

The portfolio loss itself is a mark-to-market consequence of emerging-market weakness and is not "low quality" in the operating sense — it is the genuine economic result. The durable concern is the -10.5pp benchmark gap: that gap implies the manager's active decisions worked against the trust during a stress period, and unlike the income line it is not mechanically expected to mean-revert. Gearing of 150.0m against a smaller equity base also means the next portfolio move, in either direction, will translate into a larger swing in NAV than in the prior year.

Unresolved

Open questions

What drove the 10.5pp underperformance versus MSCI EM — country allocation, stock selection, or factor positioning?
Why was gearing increased by 50.0m during a year of accelerating emerging-market weakness, and what is the framework for sizing leverage going forward?
How does the manager view the 3.80p ordinary distribution relative to a normalised income trajectory, particularly given no special was declared this year?
What changes, if any, to portfolio positioning, country weights, or sector tilts is the manager making in response to the benchmark gap?
Will the expense ratio remain at 0.97% on a smaller asset base, or is there fee leverage going the wrong way as net assets shrink?

This briefing cannot assess forward manager outlook, portfolio positioning detail, or any planned rebalancing because no such commentary is included in the supplied excerpts.

Chat

Ask about TEM FY22

Ask follow-up questions about Templeton Emerging Markets Investment Trust Plc's FY22 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about TEM FY22

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Templeton Emerging Markets Investment Trust Plc's FY22 result.

What drove the 10.5pp underperformance versus MSCI EM — country allocation, stock selection, or factor positioning?Why does "Active positioning amplified the drawdown, not cushioned it" matter?How strong was the cash and earnings quality in FY22?What should I watch next for TEM after FY22?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Statement of Annual Results to 31 March 2021

FY22 / financial report↗

Prior comparable period

Statement of Annual Results to 31 March 2021

FY21 / financial report↗

Interim context

Half-year Report

HY22 / financial report↗

Release context

Result of AGM

HY22 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

This result includes a statutory earnings-quality distortion flag.

→

Revenue growth context

Revenue growth was 89.5% for this reporting period.

→

ROE and capital efficiency

ROE was -18.9%, -61.7pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when TEM publishes next

Get the next Templeton Emerging Markets Investment Trust Plc briefing and related NZX reporting-season updates by email.